Показано 0 из 0
Дата |
---|
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
|
3.50
|
2.70
|
2.46
|
2.70
|
2.49
|
|
|
884.30
|
18.00
|
2.20
|
3.50
|
2.78
|
2.40
|
2.78
|
2.40
|
|
|
1 510.39
|
24.00
|
|
3.33
|
2.49
|
2.49
|
2.68
|
2.55
|
|
|
898.95
|
25.00
|
2.15
|
2.63
|
2.89
|
2.35
|
2.89
|
2.60
|
|
|
1 680.00
|
25.00
|
2.50
|
3.37
|
2.41
|
2.41
|
2.76
|
2.76
|
|
|
5 462.05
|
33.00
|
2.21
|
2.72
|
2.53
|
2.53
|
2.59
|
2.5308
|
|
|
3 739.21
|
10.00
|
2.37
|
2.72
|
2.40
|
2.40
|
2.51
|
2.50
|
|
|
595.58
|
10.00
|
2.21
|
2.68
|
2.50
|
2.37
|
2.60
|
2.53
|
|
|
3 556.91
|
18.00
|
2.55
|
3.14
|
2.71
|
2.51
|
2.71
|
2.51
|
|
|
2 941.70
|
11.00
|
2.54
|
2.67
|
2.78
|
2.50
|
2.78
|
2.665
|
|
|
3 831.55
|
22.00
|
AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology.